Small Compound 6-O-Angeloylplenolin Induces Mitotic Arrest and Exhibits Therapeutic Potentials in Multiple Myeloma - Concepedia

Concepedia

Publication | Open Access

Small Compound 6-O-Angeloylplenolin Induces Mitotic Arrest and Exhibits Therapeutic Potentials in Multiple Myeloma

DOI Full Paper Access

49

Citations

50

References

2011

Year

Ying Liu, Xiao-qin Chen, Heng-Xing Liang, Feng-xiang Zhang, Bo Zhang, Jie Jin, Yong-Long Chen, Yong-Xian Cheng, Guang‐Biao Zhou

Abstract

These results indicate that 6-OAP is a new cell cycle inhibitor which shows therapeutic potentials for MM.

References

	Year	Citations
Global cancer statistics Ahmedin Jemal, Freddie Bray CA A Cancer Journal for Clinicians	2011	55K
Global Cancer Statistics, 2002 Donald Maxwell Parkin, Freddie Bray, Jacques Ferlay, CA A Cancer Journal for Clinicians Epidemiology Of CancerWorldwide IncidenceCancer RegistrationCancer DeathCancer Risk Factors	2005	18.4K
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma Paul G. Richardson, Bart Barlogie, James R. Berenson, New England Journal of Medicine	2003	2.6K
Antitumor Activity of Thalidomide in Refractory Multiple Myeloma Seema Singhal, Jayesh Mehta, Raman Desikan, New England Journal of Medicine	1999	2.6K
Bortezomib or High-Dose Dexamethasone for Relapsed Multiple Myeloma Paul G. Richardson, Pieter Sonneveld, Michael W. Schuster, New England Journal of Medicine	2005	2.5K
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas Michio Kawano, Toshio Hirano, Tadashi Matsuda, Nature Hematological MalignancyImmunologyHematologyPathologyBlood Cell	1988	1.7K
Constitutive Activation of Stat3 Signaling Confers Resistance to Apoptosis in Human U266 Myeloma Cells Robyn Catlett-Falcone, Terry H. Landowski, Marc M. Oshiro, Immunity Cell RegulationConstitutive ActivationMedicineApoptosisImmunology	1999	1.6K
The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells. Teru Hideshima, Paul G. Richardson, D Chauhan, PubMed Proteasome InhibitorsHuman Mm CellsApoptosisImmunologyCell Death	2001	1.5K
Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma Meletios Α. Dimopoulos, Andrew Spencer, Michael Attal, New England Journal of Medicine	2007	1.4K
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer Arkaitz Carracedo, Li Ma, Julie Teruya‐Feldstein, Journal of Clinical Investigation	2008	1.4K

Page 1